Literature DB >> 31923070

Sexual and Reproductive Health Characteristics of Women in Substance Use Treatment in Michigan.

Lauren K MacAfee1, Roxanne F Harfmann, Lindsay M Cannon, Giselle Kolenic, Yasamin Kusunoki, Mishka Terplan, Vanessa K Dalton.   

Abstract

OBJECTIVE: To evaluate the sexual and reproductive health characteristics of women in treatment for opioid use disorder in Michigan and explore services provided and desired.
METHODS: We conducted a cross-sectional study of female patients aged 18-50 years who accessed opioid use disorder treatment at 22 randomly selected facilities in Michigan from December 2015 to May 2017. Computer-assisted self-interviews were completed using online survey management software to assess prior substance use and use disorder treatment, sexual and reproductive health history, and sexual and reproductive health services received in the previous 12 months through a treatment program, and desire for and barriers to sexual and reproductive health services within substance use disorder treatment. Descriptive statistics were calculated.
RESULTS: The final sample consisted of 260 participants. About half (51.5%) had ever had an abnormal Pap test result, and 57.3% had ever tested positive for a sexually transmitted infection. Unintended pregnancy was common (61.2%), as was substance use during pregnancy (74.2%). Nearly half (46.5%) were not currently using a method of contraception, and only 28.5% were using a highly effective method. Common barriers to accessing reproductive health services included fear of being treated poorly or judged because of substance use, fear of child protective services, and structural barriers such as cost and lack of transportation. Most participants (80.4%) indicated interest in receiving sexual and reproductive health services on site or by referral from their substance use disorder treatment programs.
CONCLUSION: Women in treatment for opioid use disorder in Michigan have high rates of adverse sexual and reproductive health experiences and face barriers to accessing care.

Entities:  

Mesh:

Year:  2020        PMID: 31923070     DOI: 10.1097/AOG.0000000000003666

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  10 in total

1.  WVSUD-PACT: a Primary-Care-Based Substance Use Disorder Team for Women Veterans.

Authors:  Sara Spinella; Nicole McCune; Rebecca McCarthy; Maria El-Tahch; Jennifer George; Mary Dorritie; Alyssa Ford; Kira Posteraro; Deborah DiNardo
Journal:  J Gen Intern Med       Date:  2022-08-30       Impact factor: 6.473

2.  A Comparison of Sex-Specific Reproductive and Sexual Health Needs between Addiction Medicine and Primary Care Treatment Settings.

Authors:  Caitlin E Martin; Anna Beth Parlier-Ahmad; Lori Beck; Vashali Jain; Mishka Terplan
Journal:  Subst Use Misuse       Date:  2022-05-23       Impact factor: 2.362

3.  Miscarriage and Abortion Among Women Attending Harm Reduction Services in Philadelphia: Correlations With Individual, Interpersonal, and Structural Factors.

Authors:  Joy D Scheidell; Janna Ataiants; Stephen E Lankenau
Journal:  Subst Use Misuse       Date:  2022-03-11       Impact factor: 2.362

4.  Chronic Pelvic Pain and Sexual Dysfunction Among Females and Males Receiving Treatment for Opioid Use Disorder.

Authors:  Geetika Reichmann; Anna Beth Parlier-Ahmad; Lori Beck; Bhushan Thakkar; Meryl Alappattu; Jeff Boissoneault; Caitlin E Martin
Journal:  Front Pain Res (Lausanne)       Date:  2022-01-11

5.  Postpartum and addiction recovery of women in opioid use disorder treatment: A qualitative study.

Authors:  Caitlin E Martin; Tawany Almeida; Bhushan Thakkar; Tiffany Kimbrough
Journal:  Subst Abus       Date:  2021-07-02       Impact factor: 3.716

6.  Sex and female empowerment (SAFE): A randomized trial comparing sexual health interventions for women in treatment for opioid use disorder.

Authors:  Hendrée E Jones; Caitlin E Martin; Kimberly R Andringa; Rachel Middlesteadt Ellerson; Elisabeth Johnson; Essence Hairston; Kevin E O' Grady
Journal:  Drug Alcohol Depend       Date:  2021-02-17       Impact factor: 4.492

Review 7.  Pre-exposure prophylaxis (PrEP) indication and uptake among people receiving buprenorphine for the treatment of opioid use disorder.

Authors:  Lori Beck; Anna Beth Parlier-Ahmad; Caitlin E Martin
Journal:  J Subst Abuse Treat       Date:  2021-05-31

8.  Treatment Outcomes Among Black Adults Receiving Medication for Opioid Use Disorder.

Authors:  Anna Beth Parlier-Ahmad; Mickeal Pugh; Caitlin E Martin
Journal:  J Racial Ethn Health Disparities       Date:  2021-07-12

9.  Menstrual Hygiene Needs Among Women Undergoing Substance Use Disorder Treatment.

Authors:  Victoria Keiser; Anna Beth Parlier-Ahmad; Anne Sebert Kuhlmann; Caitlin E Martin
Journal:  Obstet Gynecol       Date:  2020-10       Impact factor: 7.623

10.  Long-acting reversible contraceptives (LARCs) as harm reduction: a qualitative study exploring views of women with histories of opioid misuse.

Authors:  Stephani L Stancil; Melissa K Miller; Alex Duello; Sarah Finocchario-Kessler; Kathy Goggin; Rachel P Winograd; Emily A Hurley
Journal:  Harm Reduct J       Date:  2021-08-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.